Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOTUM | Q6P988 | 1/20 | 0.42 |
| ▸ | DRD2 | P14416 | 2/20 | 0.38 |
| ▸ | DRD4 | P21917 | 2/20 | 0.38 |
| ▸ | DRD3 | P35462 | 1/20 | 0.33 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.33 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.33 |
| ▸ | PIM1 | P11309 | 1/20 | 0.32 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.31 |
| ▸ | HTR3B | O95264 | 1/20 | 0.31 |
| ▸ | HTR3A | P46098 | 1/20 | 0.31 |
| ▸ | HTR3D | Q70Z44 | 1/20 | 0.31 |
| ▸ | HTR3C | Q8WXA8 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29363884 | 0.88 | NOTUM (0.36) | NOTUMDRD2DRD4CHRNB2CHRNA4 | |
| SCHEMBL20572197 | 0.88 | NOTUM (0.36) | NOTUMDRD2DRD4CHRNB2CHRNA4 | |
| SCHEMBL27061517 | 0.79 | DRD2 (0.34) | NOTUMDRD2DRD4DRD3ALDH1A1 | |
| SCHEMBL31253032 | 0.75 | DRD2 (0.34) | NOTUMDRD2DRD4ALDH1A1KMT2A | |
| SCHEMBL13400071 | 0.75 | CCR1 (0.34) | NOTUMDRD2DRD4ALDH1A1KMT2A | |
| SCHEMBL15676981 | 0.75 | DRD2 (0.34) | NOTUMDRD2DRD4ALDH1A1KMT2A | |
| SCHEMBL24992649 | 0.73 | CHRNB2 (0.37) | CHRNB2CHRNA4ALDH1A1HTR3EHTR3B | |
| SCHEMBL30173073 | 0.73 | CHRNB2 (0.37) | CHRNB2CHRNA4ALDH1A1HTR3EHTR3B | |
| SCHEMBL3403552 | 0.73 | GRM5 (0.46) | PIM1PIM2ACHE | |
| SCHEMBL18995627 | 0.72 | NOTUM (0.35) | NOTUMDRD2DRD4ALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8481731-B2 | Compounds, pharmaceutical composition and methods relating thereto | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2013-07-09 | — | — | US | disclosed |
| US-20110021491-A1 | COMPOUNDS, PHARMACEUTICAL COMPOSITION AND METHODS RELATING THERETO | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2011-01-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110021491-A1 | COMPOUNDS, PHARMACEUTICAL COMPOSITION AND METHODS RELATING THERETO | SLC10A1, NPY4R, CYP4B1 | NOTUM 985/4885DRD2 1887/4885DRD4 874/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.